Cargando…

Erratum to: Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective

Detalles Bibliográficos
Autores principales: Bentley, Anthony, Gillard, Samantha, Spino, Michael, Connelly, John, Tricta, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713981/
http://dx.doi.org/10.1007/s40273-013-0101-2
_version_ 1782410236802367488
author Bentley, Anthony
Gillard, Samantha
Spino, Michael
Connelly, John
Tricta, Fernando
author_facet Bentley, Anthony
Gillard, Samantha
Spino, Michael
Connelly, John
Tricta, Fernando
author_sort Bentley, Anthony
collection PubMed
description
format Online
Article
Text
id pubmed-4713981
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-47139812016-01-21 Erratum to: Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective Bentley, Anthony Gillard, Samantha Spino, Michael Connelly, John Tricta, Fernando Pharmacoeconomics Erratum Springer International Publishing 2013-11-05 2013 /pmc/articles/PMC4713981/ http://dx.doi.org/10.1007/s40273-013-0101-2 Text en © Springer International Publishing Switzerland 2013
spellingShingle Erratum
Bentley, Anthony
Gillard, Samantha
Spino, Michael
Connelly, John
Tricta, Fernando
Erratum to: Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective
title Erratum to: Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective
title_full Erratum to: Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective
title_fullStr Erratum to: Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective
title_full_unstemmed Erratum to: Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective
title_short Erratum to: Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective
title_sort erratum to: cost–utility analysis of deferiprone for the treatment of β-thalassaemia patients with chronic iron overload: a uk perspective
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713981/
http://dx.doi.org/10.1007/s40273-013-0101-2
work_keys_str_mv AT bentleyanthony erratumtocostutilityanalysisofdeferiproneforthetreatmentofbthalassaemiapatientswithchronicironoverloadaukperspective
AT gillardsamantha erratumtocostutilityanalysisofdeferiproneforthetreatmentofbthalassaemiapatientswithchronicironoverloadaukperspective
AT spinomichael erratumtocostutilityanalysisofdeferiproneforthetreatmentofbthalassaemiapatientswithchronicironoverloadaukperspective
AT connellyjohn erratumtocostutilityanalysisofdeferiproneforthetreatmentofbthalassaemiapatientswithchronicironoverloadaukperspective
AT trictafernando erratumtocostutilityanalysisofdeferiproneforthetreatmentofbthalassaemiapatientswithchronicironoverloadaukperspective